Literature DB >> 25948558

Ebola and cholera.

David R Nalin1, Norbert Hirschhorn2.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25948558      PMCID: PMC4426290          DOI: 10.4269/ajtmh.15-0169

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
Dear Sir: The description of the clinical course of Ebola virus disease (EVD) provided by Igonoh1 is consistent with mounting evidence indicating that a significant proportion of Ebola mortality is attributable to diarrheal dehydration with severe electrolyte losses.2–6 It is likely that EVD mortality could be reduced below reported levels if therapy could be streamlined as it has been for treatment of cholera. Reports of severe hyponatremia and hypokalemia in EVD suggest that stool sodium and potassium losses may exceed those in the current World Health Organization (WHO) low-sodium oral rehydration solution (ORS). Analysis of EVD stool electrolyte content would help define optimal ORS salt formulations for EVD, but unfortunately have not been reported. Such data are needed to identify the optimal standard ORS composition for EVD treatment.
  6 in total

1.  Clinical care of two patients with Ebola virus disease in the United States.

Authors:  G Marshall Lyon; Aneesh K Mehta; Jay B Varkey; Kent Brantly; Lance Plyler; Anita K McElroy; Colleen S Kraft; Jonathan S Towner; Christina Spiropoulou; Ute Ströher; Timothy M Uyeki; Bruce S Ribner
Journal:  N Engl J Med       Date:  2014-11-12       Impact factor: 91.245

2.  Ebola virus disease in West Africa--clinical manifestations and management.

Authors:  Daniel S Chertow; Christian Kleine; Jeffrey K Edwards; Roberto Scaini; Ruggero Giuliani; Armand Sprecher
Journal:  N Engl J Med       Date:  2014-11-05       Impact factor: 91.245

3.  Provision of care for Ebola.

Authors:  Michael Jacobs; Mike Beadsworth; Matthias Schmid; Anne Tunbridge
Journal:  Lancet       Date:  2014-12-02       Impact factor: 79.321

4.  Doing today's work superbly well--treating Ebola with current tools.

Authors:  François Lamontagne; Christophe Clément; Thomas Fletcher; Shevin T Jacob; William A Fischer; Robert A Fowler
Journal:  N Engl J Med       Date:  2014-09-24       Impact factor: 91.245

5.  A case of severe Ebola virus infection complicated by gram-negative septicemia.

Authors:  Benno Kreuels; Dominic Wichmann; Petra Emmerich; Jonas Schmidt-Chanasit; Geraldine de Heer; Stefan Kluge; Abdourahmane Sow; Thomas Renné; Stephan Günther; Ansgar W Lohse; Marylyn M Addo; Stefan Schmiedel
Journal:  N Engl J Med       Date:  2014-10-22       Impact factor: 91.245

6.  My experience as an Ebola patient.

Authors:  Adaora K Igonoh
Journal:  Am J Trop Med Hyg       Date:  2014-12-22       Impact factor: 2.345

  6 in total
  2 in total

1.  Incubation periods impact the spatial predictability of cholera and Ebola outbreaks in Sierra Leone.

Authors:  Rebecca Kahn; Corey M Peak; Juan Fernández-Gracia; Alexandra Hill; Amara Jambai; Louisa Ganda; Marcia C Castro; Caroline O Buckee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-13       Impact factor: 11.205

2.  Ebola Virus Causes Intestinal Tract Architectural Disruption and Bacterial Invasion in Non-Human Primates.

Authors:  Ronald B Reisler; Xiankun Zeng; Christopher W Schellhase; Jeremy J Bearss; Travis K Warren; John C Trefry; George W Christopher; Mark G Kortepeter; Sina Bavari; Anthony P Cardile
Journal:  Viruses       Date:  2018-09-20       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.